CN Patent

CN102908310A — 一种犬、猫用治疗类风湿性关节炎的美洛昔康注射液

Assigned to QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd · Expires 2013-02-06 · 13y expired

What this patent protects

本发明公开了一种用于治疗犬、猫类风湿性关节炎的注射液的制备方法，为昔康类非甾体抗炎药，给药途径为肌肉注射，本发明的药物具有祛风除湿、补肾驱寒、活血通络、强筋健骨的功效。在治疗类风湿性关节炎过程中，取得了显著效果。

USPTO Abstract

本发明公开了一种用于治疗犬、猫类风湿性关节炎的注射液的制备方法，为昔康类非甾体抗炎药，给药途径为肌肉注射，本发明的药物具有祛风除湿、补肾驱寒、活血通络、强筋健骨的功效。在治疗类风湿性关节炎过程中，取得了显著效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN102908310A
Jurisdiction
CN
Classification
—
Expires
2013-02-06
Drug substance claim
No
Drug product claim
No
Assignee
QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.